Skip to main content
. 2019 Oct 3;37(33):3142–3151. doi: 10.1200/JCO.19.00489

FIG A1.

FIG A1.

Kaplan Meier estimates for the whole patient group (V600 and non-V600) for (A) progression-free survival (PFS) and (B) overall survival (OS). Median PFS was generally lower in patients with non-V600 melanoma. Both groups showed no significant difference in overall PFS and OS likely due to small numbers of patients. Median PFS was 6.0 months for patients with V600 and 2.6 months for non-V600 mutated melanoma (P = .63); median OS was 12.3 months for V600 and 7.8 months for non-V600 melanomas (P = .74)